View Author
scopus: 6506403114

Westbroek, I.

( I. Westbroek)


osteoblast group differentiation level effect study culture animal femoral control 1/2 osteoblast differentiation fl uoxetine-treated animals treatment erk 1/2 phosphorylation matrix sample fl uoxetine fenofibrate agonist signi ficantly uoxetine protein figure phosphorylation pioglitazone body weight signi serotonin adiponectin femur ovariectomized volume leptin receptor pio ovx group activation plasma activity osteogenic factors stretch factor month expression difference mineralization bone architecture analysis weight compound nondifferentiating alpl activity fl uoxetine treatment osteogenic trabecular strain formation urine sham group model feno ovx result extracellular matrix bone metabolism matrix mineralization filing 0.001 density ficantly experiment marrow pparg presence signal control animals tissue osteoclast architecture uoxetine-treated peroxisome




5 Most Recent Publications

The peroxisome proliferator-activated receptor (PPAR) alpha agonist fenofibrate maintains bone mass, while the PPAR gamma agonist pioglitazone exaggerates bone loss, in ovariectomized rats (Article)
Stunes, A.K. Westbroek, I. Gustafsson, B.I. Fossmark, R. Waarsing, J.H. Eriksen, E.F. Petzold, C. Reseland, J.E. Syversen, U.
2011-01-01
CE-MS for metabolic profiling of volume-limited urine samples: Application to accelerated aging TTD mice (Article)
Nevedomskaya, E. Ramautar, R. Derks, R. Westbroek, I. Zondag, G. Pluijm, I. van der Deelder, A.M. Mayboroda, O.A.
2010-09-03
Wnt signaling acts and is regulated in a human osteoblast differentiation dependent manner (Article)
Eijken, H.J.M. Meijer, I.M.J. Westbroek, I. Koedam, M. Chiba, H. Uitterlinden, A.G. Pols, H.A.P. Leeuwen, J.P.T.M. van
2008-05-15
Long-term fluoxetine administration does not result in major changes in bone architecture and strength in growing rats (Article)
Westbroek, I. Waarsing, J.H. Leeuwen, J.P.T.M. van Waldum, H. Reseland, J.E. Weinans, H.H. Syversen, U. Gustafsson, B.I.
2007-05-01
Stretch-induced phosphorylation of ERK1/2 depends on differentiation stage of osteoblasts (Article)
Jansen, J.H.W. Weyts, F.A.A. Westbroek, I. Jahr, H. Chiba, H. Pols, H.A.P. Verhaar, J.A.N. Leeuwen, J.P.T.M. van Weinans, H.H.
2004-10-01